Home » Topics » Regulatory » Patents

Patents
RSS

Cephalon discloses cysteine/serine protease inhibitors

March 19, 1997

Antitumor/antiviral distamycin derivatives from P&U

March 19, 1997

Differentiation-inducing retinoid-related compounds disclosed by Eisai

March 18, 1997

Roche prepares new antiviral agents

March 18, 1997

Peptides for Japanese cedar allergies reported by Sankyo and Hayashibara

March 18, 1997

Antiatherosclerotic compounds described by Fuji Photo Film

March 18, 1997

Taisho claims orally active antiplatelet agents

March 18, 1997

Neuroprotective, analgesic and antitussive agents from Toray

March 18, 1997

Antihepatitis agents from Mitsubishi Chemical

March 18, 1997

Selective cGMP-PDE inhibitors claimed by Otsuka

March 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...